COX-2 in brain and spinal cord implications for therapeutic use.
about
Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course studyA novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activityDiverse methyl sulfone-containing benzo[b]thiophene library via iodocyclization and palladium-catalyzed coupling.Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged swordEstradiol and the developing brainInduction of cell cycle arrest and apoptosis with downregulation of Hsp90 client proteins and histone modification by 4β-hydroxywithanolide E isolated from Physalis peruviana.Neuroprotection and acute spinal cord injury: a reappraisalLipid signaling in experimental epilepsy.Cellular mechanisms of estradiol-mediated masculinization of the brain.Renal adverse effects of nonsteroidal anti-inflammatory drugs.COX-2 inhibition and pain management: a review summary.Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression.p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes.Sodium thiosulphate attenuates brain inflammation induced by systemic lipopolysaccharide administration in C57BL/6J mice.NCX 2057, a novel NO-releasing derivative of ferulic acid, suppresses inflammatory and nociceptive responses in in vitro and in vivo models.Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas.Reversal of LPS-induced central and peripheral hyperalgesia by green tea extract.
P2860
Q21261389-BBFB07E2-1014-440C-8837-8D5E3E01F56EQ28200568-C0CD1E69-BF0C-4386-80B7-485B8F2A15CAQ33522431-78B86071-9982-4647-BEF8-6233351AF76AQ33565825-4F7726EE-6103-47F2-A893-2A91A60D3503Q34157706-558D7545-FEAC-49E4-89BC-3EF27786473CQ34736012-DD0D2A7E-0837-4D04-A084-11D5BF2A17F5Q35967052-4A399D9F-84D6-4B71-B77A-65F53E89DF0CQ36045235-26B9C9CB-19B1-47C2-BF45-F00A0FA0CFF8Q36269302-0F50BF9A-FCE3-423C-BB46-78B0EF4ACC5CQ36804460-F01F4DED-3492-4F58-AADD-FDC0F3EE6E24Q37615395-138DDC9F-C1DA-476B-B06C-183498955D70Q37754624-320782CB-F37C-42F2-9F18-01C717CAC583Q37963769-1289727F-9B6F-49FB-BA5F-10A86F0EB84AQ39207170-F7472861-8975-43CB-88FA-94D4C1798C96Q40011246-B3E86215-6674-4E54-8C1A-0CD9C0DF8DE9Q40205263-68FB463A-4173-4D93-9C73-BE141DF1B597Q42577499-4B1E9401-305E-4794-AE2B-1E3E5EC89B73Q44949899-C1E85F83-D47E-40E5-8AFB-AC13CDE94170Q46411628-4A8DF9BD-CA39-41D6-82B9-F03D6899C8A0
P2860
COX-2 in brain and spinal cord implications for therapeutic use.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
COX-2 in brain and spinal cord implications for therapeutic use.
@ast
COX-2 in brain and spinal cord implications for therapeutic use.
@en
COX-2 in brain and spinal cord implications for therapeutic use.
@nl
type
label
COX-2 in brain and spinal cord implications for therapeutic use.
@ast
COX-2 in brain and spinal cord implications for therapeutic use.
@en
COX-2 in brain and spinal cord implications for therapeutic use.
@nl
prefLabel
COX-2 in brain and spinal cord implications for therapeutic use.
@ast
COX-2 in brain and spinal cord implications for therapeutic use.
@en
COX-2 in brain and spinal cord implications for therapeutic use.
@nl
P356
P1476
COX-2 in brain and spinal cord implications for therapeutic use.
@en
P2093
Hoffmann C
P304
P356
10.2174/0929867003374282
P577
2000-11-01T00:00:00Z